Study number 8538-373
Dates
Feb 26 2025-Jul 11 2025
Location
Dallas, Texas
Age
22-65
Gender
Both Males and Females
Compensation
$16,688
Group
G2 B3
The investigational drug in this research study is being developed for the potential treatment of type 2 diabetes mellitus, alongside diet, exercise, and oral medications. In addition, it is being developed for use as an aid to healthy diet and physical activity to manage body weight in adult patients with obesity or who are overweight. This study will also look at how the study drug affects smoking habits.
Fortrea Dallas, TX is recruiting for:
- Healthy Men and Women of Non-childbearing potential, age 22-65
- Body Mass Index between 22-26.9*
- Study involves 4 separate stays totaling 11 nights & 12 follow-up visits
- Compensation up to $16,688 may be provided for time and participation
- Refer a friend to receive $500 per qualified referral
*60kg or more at screening
G2 B3:
Check-in: Feb 26, Mar 27, Apr 24, May 15
Check-out: Mar 3, 28, Apr 25, May 19
OPV: Mar 7, 14, 21, Apr 4, 11, 18, May 2, 9, May 23, 30, Jun 20, Jul 11,
Compensation Breakdown:
After completing Day 8: $4,651
After completing Day 36: $2,241
After completing Day 64: $2,241
After completing Day 92: $4,437
After completing Day 134: $3,118